Skip to main content

Judge rejects bid by 'Pharma bro' Martin Shkreli to delay paying more than $24.6 million in FTC lawsuit related to medication

Martin Shkreli lost the civil case involving the drug Daraprim while serving a criminal sentence for unrelated securities fraud.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.